Article Information
History
- January 14, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kaiming Bi1,⤉,
- Jose Luis Herrera-Diestra1,⤉,
- Yuan Bai2,3,⤉,
- Zhanwei Du2,3,
- Lin Wang4,
- Graham Gibson1,
- Maureen Johnson-Leon1,
- Spencer J. Fox1 and
- Lauren Ancel Meyers1,5,*
- 1The University of Texas at Austin, Austin, Texas 78712, The United States of America
- 2WHO Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China
- 3Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China
- 4University of Cambridge, Cambridge CB2 3EH, UK
- 5Santa Fe Institute, Santa Fe, New Mexico, The United States of America
- ↵*Correspondence: Lauren Ancel Meyers (Email: laurenmeyers{at}austin.utexas.edu)
↵⤉ These first authors contributed equally to this article
Posted January 14, 2022.
The risk of SARS-CoV-2 Omicron variant emergence in low and middle-income countries (LMICs)
